Endive vs Aidy for Crohn's: Food Triggers and Treatment
By the Aidy Editorial Team
First Published Apr 25, 2026Last Updated Aug 19, 2026
Endive's listing centers food; Aidy gives Crohn's users a broader daily care view. Endive's listings claim calorie-free meal, symptom, mood, recipe, and custom-field tracking. Aidy keeps food inside an IBD record that also covers stool, symptoms, treatment, disease activity, education, and appointments.
Quick answer: For most people with Crohn's, choose Aidy as the primary tracker for free treatment-aware logging, modified HBI trends, and reports. Endive is the genuine exception for someone who wants its advertised calorie-free food diary with recipe-level ingredient tracking.
| Decision factor | Aidy | Endive (public claims) |
|---|---|---|
| Best for | Full Crohn's record | Claims focused food journaling |
| Daily IBD record | Food, stool, symptoms, treatment | Claims food, symptoms, moods, recipes |
| Treatment tools | Medicines and biologic schedules | Claims no comparable workflow |
| Reports and insights | Modified HBI and reports | Claims visual correlations |
| Access and cost | Free | Claims optional Endive Plus |
| Overall pick | Aidy | Food-diary exception |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
Endive Makes Food Logging Approachable
A balanced Endive app review starts with the current iPhone listing, which describes a simple diary for foods, symptoms, moods, and visual correlations. The developer says users can add custom foods and symptoms, while the recipe feature breaks a mixed meal into ingredients. The product avoids calories and weight-loss framing in its public description, which can make tracking feel more neutral. The listing also names Crohn's disease and IBD among many supported conditions.
Endive's listings show current versions on both platforms, and the Android listing reports more than 10,000 downloads. Its strength is focus: the listings describe meals and symptoms in a shared visual record without a complete chronic-disease setup. Its published features do not specify Crohn's treatment schedules, a named IBD activity score, or detailed appointment reporting.
A Food Correlation Is a Starting Point
As a Crohn's food trigger app, Endive's listing says its graph centers on correlations between food and digestive symptoms. Aidy also provides a personalized pattern view. People researching food symptom correlation IBD can use either workflow to remember timing and formulate a question. NIDDK says a clinician may suggest a food diary to identify foods that seem related to Crohn's symptoms, while researchers have not found that specific foods cause or worsen those symptoms (NIDDK).
Food associations also cannot establish whether Crohn's inflammation is active. The AGA Crohn's guideline recommends using symptoms with biomarkers in several monitoring situations. NIDDK explains that blood tests, stool tests, endoscopy, and imaging may be used to diagnose or assess disease. Endive is useful for symptom-provoking food questions. Aidy's broader record is more appropriate when the question also involves disease activity or treatment response.
Aidy Connects Meals to Treatment
Aidy supports meal photos or text, Bristol stool entries, custom and common symptoms, medication adherence, food correlations, and doctor-ready reports. It also supports named biologics through induction and maintenance, with dose countdowns, injection-site rotation, post-injection or infusion check-ins, and later route or interval changes. Endive's official store descriptions do not advertise comparable medication or biologic logistics.
Aidy automatically calculates a modified Harvey-Bradshaw Index from logged information. HBI is easier to collect than the longer Crohn's Disease Activity Index, although their relationship is imperfect (PubMed). That makes it a structured conversation aid. It cannot prove remission or inflammation. A systematic review of IBD apps found that available tools span education, monitoring, counseling, diagnosis, and treatment, while capabilities for identifying disease severity remain limited. Aidy's advantage is combining more of those practical jobs in one Crohn's-specific record.
Price and Privacy Need a Close Read
Apple lists Endive as free to download with in-app purchases; its Endive Plus price is $5.99 monthly or $35.99 annually in the US. The public listing does not map each advertised feature to the free or paid tier. Endive's privacy policy says it collects entered food, symptom, health, and mood data, plus account and usage information. It also describes disclosures to service providers that may include hosting, analytics, marketing, advertising, and payment services. The policy is dated March 2020, despite recent app updates.
Aidy encrypts data, runs no ads, does not sell user data, and is free with no paid user subscriptions. Endive publishes subscription amounts, while Aidy provides its complete workflow without a patient subscription. Aidy also has the stronger no-ad model and lower-cost positioning.
Which App Fits the Daily Job?
Endive wins if the desired job is a visually simple, non-calorie food and mood journal on iPhone or Android. Its advertised recipe breakdown is especially useful when a mixed dish would otherwise become one vague entry. People focused on IBS-style food experimentation may prefer that narrower experience.
Aidy is the better Endive alternative for Crohn's disease. It captures meals without treating diet as the whole condition, then adds stool detail, treatment adherence, biologic timing, post-dose observations, HBI trends, education, and a care-team report. That integrated context matters when the same symptom could prompt questions about food, medication timing, or inflammation. Endive remains a capable specialist diary. Aidy is the stronger primary record for continuous, treatment-aware Crohn's management.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.